Infusions of immune cells called macrophages were associated with improved outcomes in people with cirrhosis. Death and the need for liver transplant were delayed among recipients of macrophage therapy. The therapy reduced the risk of death and liver transplant compared with expected outcomes. The findings link macrophage treatment to better survival and fewer transplant requirements in cirrhosis patients.
"Infusions of immune cells called macrophages have been linked to a reduction in the risk of death and the need for a liver transplant in people with cirrhosis."
"Death and the need for liver transplant were delayed in people with cirrhosis who received macrophage therapy."
Read at Nature
Unable to calculate read time
Collection
[
|
...
]